Project Grant HT94252510399
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$534K
Federal Agency
Defense Health Agency
Awardee
Brown University (E3FDXZ6TBHW3)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Providence, RI 02912, USA
Similar Awards
This $672,694 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports Brown University's research on optimizing RNA lipid nanoparticles (LNPs) to generate cellular immunity for treating metastatic breast cancer. The project will be conducted over 3 years, with a start date of September 1, 2025 and a completion date of August 31, 2028. As a leading research university, Brown has a strong track record of delivering...
This $729,778 federal Project Grant award, issued by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports multiomic analysis of liquid biopsies for biomarker discovery and therapeutic targeting. The 3-year award to the University of Wisconsin System, which commenced on June 1, 2025, will fund advanced research into transforming healthcare for military service members and the broader public through innovative scientific investigations...
This federal Project Grant award, totaling $4,991,950.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant is funding the "INVESTIGATION OF A MULTICANCER EARLY DETECTION TEST IN A HIGH-RISK MILITARY POPULATION" at the Dana-Farber Cancer Institute, Inc. (DFCI) in Boston, Massachusetts. The project aims to develop and evaluate a novel multicancer early detection test for use within a high-risk military...
The Defense Health Agency awarded a $1,116,955 Project Grant to The Broad Institute, Inc. to identify new therapies and therapeutic targets in gastroesophageal cancer. This 3-year grant, running from August 15, 2023 to August 14, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420). The Broad Institute, a non-profit biomedical and genomic research organization, will leverage its expertise in areas like genomic sequencing, data analysis, and translational...
The Department of Defense Basic Scientific Research program (CFDA 12.431) has awarded a $241,631.00 Project Grant to Brown University, with a performance period from Aug 1, 2024 to Jul 31, 2027. This grant supports fundamental and applied research across diverse scientific and technical domains critical to national security, with a focus on advancing knowledge in areas such as quantum computing, artificial intelligence, materials science, robotics, defense technologies, and behavioral...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
The Defense Health Agency has awarded a $1,581,751 Project Grant to Duke University to conduct the "THERAPEUTIC INTERVENTION TO REVERSE GASTRIC PRECANCER" research project under the Military Medical Research and Development program (CFDA 12.420). This federal grant, with a performance period from June 1, 2024 to May 31, 2028, will enable Duke University's researchers to investigate innovative therapeutic interventions to reverse precancerous gastric conditions. The Military Medical...
This Project Grant from the Defense Health Agency will fund $159,128 to Brown University for research on the antitumor activity of kasugamycin in primary and metastatic lung cancer. The award period is from February 15, 2022 to August 14, 2023. The funding falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research aimed at transforming military and public health care through innovative medical solutions for...
This federal Project Grant award of $440,000.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research by Baylor College of Medicine on "Biopolymers for Intestinal Healing and Immune Modulation to Treat Inflammatory Bowel Disease". The 2-year award, running from January 15, 2025 to January 14, 2027, will fund advanced biomedical research initiatives focused on transforming healthcare for military service...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,774,998.00 to the Coriell Institute for Medical Research, Inc., a non-profit biomedical research center, to conduct research on exosomal galectin-3 mediated stromal activation and immunosuppression in advanced gastric adenocarcinoma. The award, effective from September 30, 2024 to September 29, 2027, supports the institute's innovative scientific...